GC
KITE

Guggenheim Capital’s Kite Pharma, Inc. KITE Stock Holding History

Guggenheim Capital’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-39,953
Closed -$7.18M – 2920
2017
Q3 		$7.18M Sell
39,953
-10,386
-21% -$1.45M 0.02% 852
2017
Q2 		$5.22M Sell
50,339
-1,691
-3% -$138K 0.01% 991
2017
Q1 		$4.08M Sell
52,030
-8,690
-14% -$537K 0.01% 1149
2016
Q4 		$2.72M Sell
60,720
-7,089
-10% -$348K 0.01% 1440
2016
Q3 		$3.79M Sell
67,809
-2,563
-4% -$143K 0.01% 1183
2016
Q2 		$3.52M Sell
70,372
-5,077
-7% -$249K 0.01% 1193
2016
Q1 		$3.46M Sell
75,449
-23,435
-24% -$1.14M 0.01% 1202
2015
Q4 		$6.09M Sell
98,884
-30,115
-23% -$2.12M 0.02% 933
2015
Q3 		$7.18M Sell
128,999
-16,233
-11% -$1.02M 0.02% 893
2015
Q2 		$8.86M Buy
145,232
+17,495
+14% +$998K 0.02% 889
2015
Q1 		$7.37M Buy
127,737
+36,854
+41% +$2.47M 0.02% 990
2014
Q4 		$5.24M Buy
+90,883
New +$3.83M 0.01% 1099

Guggenheim Capital's KITE Position: Q4 2017 in Review

Guggenheim Capital sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 39,953 shares — an estimated $7.18M sold.

Guggenheim Capital first reported a position in KITE in Q4 2014 and held it in 12 quarters. The position peaked at $8.86M in Q2 2015. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Guggenheim Capital reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Guggenheim Capital sold 39,953 Kite Pharma, Inc. shares in Q4 2017, an estimated $7.18M.
  • Guggenheim Capital first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 12 quarters.
  • Guggenheim Capital's Kite Pharma, Inc. position peaked at $8.86M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Guggenheim Capital's 13F filing for Q4 2017, filed 14 Feb 2018.